<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41001121</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-861X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in nutrition</Title><ISOAbbreviation>Front Nutr</ISOAbbreviation></Journal><ArticleTitle>Impact of a high-fat, low-carbohydrate ketogenic diet on seizure frequency in children with drug-resistant epilepsy: a systematic review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1634041</StartPage><MedlinePgn>1634041</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1634041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2025.1634041</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Drug-resistant epilepsy in children poses significant therapeutic challenges. The ketogenic diet (KD), characterized by high-fat and low-carbohydrate content, has emerged as a potential adjunctive treatment. This meta-analysis aimed to systematically evaluate the impact of the KD on seizure frequency in pediatric patients with drug-resistant epilepsy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Following PRISMA guidelines, PubMed, Embase, Web of Science, and the Cochrane Library were searched to identify randomized and quasi-randomized trials of classical KD, modified Atkins diet (MAD), and low-glycemic-index treatment (LGIT) in children (&#x2264;18&#x202f;years) with DRE. Two reviewers independently screened studies, extracted data, and assessed quality using the Cochrane Risk of Bias Tool 2.0. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed- or random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Nine studies met the inclusion criteria. For patients achieving &gt;50% seizure reduction, pooled analysis (random-effects model; I<sup>2</sup>&#x202f;=&#x202f;60.5%, <i>p</i>&#x202f;=&#x202f;0.009) revealed an OR of 7.69 (95% CI [3.42, 17.3]). Analysis of studies reporting &gt;90% seizure reduction (fixed-effects model; I<sup>2</sup>&#x202f;=&#x202f;0.0%, <i>p</i>&#x202f;=&#x202f;0.749) yielded an OR of 8.54 (95% CI [3.13, 23.31]). In the subset evaluating seizure freedom, the pooled OR was 7.35 (95% CI [2.17, 24.88]) with minimal heterogeneity (I<sup>2</sup>&#x202f;=&#x202f;4.4%, <i>p</i>&#x202f;=&#x202f;0.371). Subgroup analyses favored the classical KD and interventions &#x2265;6&#x202f;months. Sensitivity analysis confirmed result stability, and Egger's test indicated no significant publication bias (<i>p</i>&#x202f;&gt;&#x202f;0.05), although the test had limited power due to the small number of included studies. The most frequent adverse events were constipation (37.5%), anorexia (19.5%), and diarrhea (18.9%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The KD significantly improved seizure outcomes, with robust efficacy in reducing seizure frequency and a higher likelihood of achieving seizure freedom, although absolute rates of seizure freedom were modest. These findings support the KD as a promising adjunctive therapy for children with drug-resistant epilepsy; however, further large-scale, long-term studies are needed to confirm its sustained efficacy and safety.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">CRD420251122427.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Liu, E, Zhang and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Pediatrics, Chifeng College Affiliated Hospital, Chifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>E</LastName><ForeName>Ri-He-Mu-Qi-Qi-Ge</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of General Pediatrics, Chifeng College Affiliated Hospital, Chifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jia-Qi</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Department of General Pediatrics, Chifeng College Affiliated Hospital, Chifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Da-Peng</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of General Pediatrics, Chifeng College Affiliated Hospital, Chifeng, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nutr</MedlineTA><NlmUniqueID>101642264</NlmUniqueID><ISSNLinking>2296-861X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">drug-resistant epilepsy</Keyword><Keyword MajorTopicYN="N">ketogenic diet</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">seizure reduction</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41001121</ArticleId><ArticleId IdType="pmc">PMC12459275</ArticleId><ArticleId IdType="doi">10.3389/fnut.2025.1634041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee J, Choi A, Kim S, Yoo IH. Trends in prevalence and incidence of epilepsy and drug-resistant epilepsy in children: a Nationwide population-based study in Korea. Neurol Int. (2024) 16:880&#x2013;90. doi: 10.3390/neurolint16040066, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint16040066</ArticleId><ArticleId IdType="pmc">PMC11357417</ArticleId><ArticleId IdType="pubmed">39195568</ArticleId></ArticleIdList></Reference><Reference><Citation>Urio OH, Kija E, Weckhuysen S, Makungu H, Naburi H. Drug resistant epilepsy and associated factors among children with epilepsies in tanzania: a cross-sectional study. BMC Neurol. (2024) 24:8. doi: 10.1186/s12883-023-03508-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-023-03508-9</ArticleId><ArticleId IdType="pmc">PMC10759687</ArticleId><ArticleId IdType="pubmed">38166885</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Mcgill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. (2020) 6:Cd001903. doi: 10.1002/14651858.CD001903.pub5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001903.pub5</ArticleId><ArticleId IdType="pmc">PMC7387249</ArticleId><ArticleId IdType="pubmed">32588435</ArticleId></ArticleIdList></Reference><Reference><Citation>U&#x142;amek-Kozio&#x142; M, Czuczwar SJ, Januszewski S, Pluta R. Ketogenic Diet and Epilepsy. Nutrients. (2019) 11:510. doi: 10.3390/nu11102510, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102510</ArticleId><ArticleId IdType="pmc">PMC6836058</ArticleId><ArticleId IdType="pubmed">31635247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells J, Swaminathan A, Paseka J, Hanson C. Efficacy and safety of a ketogenic diet in children and adolescents with refractory epilepsy-a review. Nutrients. (2020) 12:809. doi: 10.3390/nu12061809, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061809</ArticleId><ArticleId IdType="pmc">PMC7353240</ArticleId><ArticleId IdType="pubmed">32560503</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the heart: metabolic principles and therapeutic implications. Circ Res. (2023) 132:882&#x2013;98. doi: 10.1161/CIRCRESAHA.123.321872, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321872</ArticleId><ArticleId IdType="pmc">PMC10289202</ArticleId><ArticleId IdType="pubmed">36996176</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahpasand S, Khatami SH, Ehtiati S, Alehossein P, Salmani F, Toutounchi AH, et al. Therapeutic potential of the ketogenic diet: a metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases. J Nutr Biochem. (2024) 132:109693. doi: 10.1016/j.jnutbio.2024.109693, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2024.109693</ArticleId><ArticleId IdType="pubmed">38880191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdonald TJW, Cervenka MC. Ketogenic diets for adults with highly refractory epilepsy. Epilepsy Curr. (2017) 17:346&#x2013;50. doi: 10.5698/1535-7597.17.6.346, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5698/1535-7597.17.6.346</ArticleId><ArticleId IdType="pmc">PMC5706352</ArticleId><ArticleId IdType="pubmed">29217974</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdonald TJW, Cervenka MC. Lessons learned from recent clinical trials of ketogenic diet therapies in adults. Curr Opin Clin Nutr Metab Care. (2019) 22:418&#x2013;24. doi: 10.1097/MCO.0000000000000596, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000596</ArticleId><ArticleId IdType="pmc">PMC7881369</ArticleId><ArticleId IdType="pubmed">31503023</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdonald TJW, Cervenka MC. Ketogenic diet therapies for seizures and status epilepticus. Semin Neurol. (2020) 40:719&#x2013;29. doi: 10.1055/s-0040-1719077, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719077</ArticleId><ArticleId IdType="pmc">PMC7883219</ArticleId><ArticleId IdType="pubmed">33155184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondhi V, Agarwala A, Pandey RM, Chakrabarty B, Jauhari P, Lodha R, et al. Efficacy of ketogenic diet, modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. (2020) 174:944&#x2013;51. doi: 10.1001/jamapediatrics.2020.2282, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.2282</ArticleId><ArticleId IdType="pmc">PMC7400196</ArticleId><ArticleId IdType="pubmed">32761191</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeler NE, Marston L, Lyons L, Halsall S, Jain R, Titre-Johnson S, et al. Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (Kiwe): a UK, multicentre, open-label, randomised clinical trial. Lancet Neurol. (2023) 22:1113&#x2013;24. doi: 10.1016/S1474-4422(23)00370-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(23)00370-8</ArticleId><ArticleId IdType="pubmed">37977712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther. (2022) 7:11. doi: 10.1038/s41392-021-00831-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00831-w</ArticleId><ArticleId IdType="pmc">PMC8761750</ArticleId><ArticleId IdType="pubmed">35034957</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The prisma 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. (2019) 366:l4898. doi: 10.1136/bmj.l4898, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kinderen RJ, Lambrechts DA, Wijnen BF, Postulart D, Aldenkamp AP, Majoie MH, et al. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: an interim analysis. Epilepsia. (2016) 57:41&#x2013;50. doi: 10.1111/epi.13254, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13254</ArticleId><ArticleId IdType="pubmed">26617284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressler A, Benninger F, Trimmel-Schwahofer P, Gr&#xf6;ppel G, Porsche B, Abraham K, et al. Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: a single-center parallel-cohort randomized controlled trial. Epilepsia. (2019) 60:441&#x2013;51. doi: 10.1111/epi.14679, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.14679</ArticleId><ArticleId IdType="pubmed">30801699</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rashidy OF, Nassar MF, Abdel-Hamid IA, Shatla RH, Abdel-Hamid MH, Gabr SS, et al. Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol Scand. (2013) 128:402&#x2013;8. doi: 10.1111/ane.12137, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12137</ArticleId><ArticleId IdType="pubmed">23679058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshminarayanan K, Agarawal A, Panda PK, Sinha R, Tripathi M, Pandey RM, et al. Efficacy of low glycemic index diet therapy (Lgit) in children aged 2-8 years with drug-resistant epilepsy: a randomized controlled trial. Epilepsy Res. (2021) 171:106574. doi: 10.1016/j.eplepsyres.2021.106574, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2021.106574</ArticleId><ArticleId IdType="pubmed">33582533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts DA, De Kinderen RJ, Vles JS, De Louw AJ, Aldenkamp AP, Majoie HJ. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand. (2017) 135:231&#x2013;9. doi: 10.1111/ane.12592</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12592</ArticleId><ArticleId IdType="pubmed">27027847</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. (2008) 7:500&#x2013;6. doi: 10.1016/S1474-4422(08)70092-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70092-9</ArticleId><ArticleId IdType="pubmed">18456557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Goel S, Jain P, Agarwala A, Aneja S. Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: a randomized controlled trial. Epilepsy Res. (2016) 127:152&#x2013;9. doi: 10.1016/j.eplepsyres.2016.09.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2016.09.002</ArticleId><ArticleId IdType="pubmed">27603509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Goel S, Kapoor D, Garg D, Panda I, Elwadhi A, et al. Evaluation of the modified Atkins diet for the treatment of epileptic spasms refractory to hormonal therapy: a randomized controlled trial. J Child Neurol. (2021) 36:686&#x2013;91. doi: 10.1177/08830738211004747, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08830738211004747</ArticleId><ArticleId IdType="pubmed">33834913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. (2013) 54:481&#x2013;6. doi: 10.1111/epi.12069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12069</ArticleId><ArticleId IdType="pubmed">23294191</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shafie AM, Bahbah WA, Abd El Naby SA, Omar ZA, Basma EM, Hegazy AAA, et al. Impact of two ketogenic diet types in refractory childhood epilepsy. Pediatr Res. (2023) 94:1978&#x2013;89. doi: 10.1038/s41390-023-02554-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-02554-w</ArticleId><ArticleId IdType="pmc">PMC10007663</ArticleId><ArticleId IdType="pubmed">36906721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A, Kwon HE, Kim HD. Updates on the ketogenic diet therapy for pediatric epilepsy. Biom J. (2022) 45:19&#x2013;26. doi: 10.1016/j.bj.2021.11.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2021.11.003</ArticleId><ArticleId IdType="pmc">PMC9133260</ArticleId><ArticleId IdType="pubmed">34808422</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci. (2021) 24:307&#x2013;16. doi: 10.1080/1028415X.2019.1627769, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2019.1627769</ArticleId><ArticleId IdType="pubmed">31241011</ArticleId></ArticleIdList></Reference><Reference><Citation>Manral M, Dwivedi R, Gulati S, Kaur K, Nehra A, Pandey RM, et al. Safety, efficacy, and tolerability of modified Atkins diet in persons with drug-resistant epilepsy: a randomized controlled trial. Neurology. (2023) 100:e1376&#x2013;85. doi: 10.1212/WNL.0000000000206776, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000206776</ArticleId><ArticleId IdType="pmc">PMC10065201</ArticleId><ArticleId IdType="pubmed">36599697</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Su X, Feng Y, Li R, Liao M, Fan L, et al. Ketogenic diet and multiple health outcomes: an umbrella review of Meta-analysis. Nutrients. (2023) 15:161. doi: 10.3390/nu15194161, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15194161</ArticleId><ArticleId IdType="pmc">PMC10574428</ArticleId><ArticleId IdType="pubmed">37836444</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsello A, Trovato CM, Di Profio E, Cardile S, Campoy C, Zuccotti G, et al. Ketogenic diet in children and adolescents: The effects on growth and nutritional status. Pharmacol Res. (2023) 191:106780. doi: 10.1016/j.phrs.2023.106780, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106780</ArticleId><ArticleId IdType="pubmed">37088260</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen NJ, Wodschow HZ, Nilsson M, Rungby J. Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci. (2020) 21:767. doi: 10.3390/ijms21228767, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228767</ArticleId><ArticleId IdType="pmc">PMC7699472</ArticleId><ArticleId IdType="pubmed">33233502</ArticleId></ArticleIdList></Reference><Reference><Citation>Enders JD, Thomas S, Lynch P, Jack J, Ryals JM, Puchalska P, et al. Atp-gated potassium channels contribute to ketogenic diet-mediated analgesia in mice. Neurobiol Pain. (2023) 14:100138. doi: 10.1016/j.ynpai.2023.100138, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynpai.2023.100138</ArticleId><ArticleId IdType="pmc">PMC10719532</ArticleId><ArticleId IdType="pubmed">38099277</ArticleId></ArticleIdList></Reference><Reference><Citation>Desli E, Spilioti M, Evangeliou A, Styllas F, Magkos F, Dalamaga M. The efficacy and safety of ketogenic diets in drug-resistant epilepsy in children and adolescents: a systematic review of randomized controlled trials. Curr Nutr Rep. (2022) 11:102&#x2013;16. doi: 10.1007/s13668-022-00405-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-022-00405-4</ArticleId><ArticleId IdType="pubmed">35303283</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. (2018) 173:1728&#x2013;1741.e13. doi: 10.1016/j.cell.2018.04.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.04.027</ArticleId><ArticleId IdType="pmc">PMC6003870</ArticleId><ArticleId IdType="pubmed">29804833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TMT, Jallon P, Korff C, Nguyen H, Nguyen The Tich S. Feasibility, tolerability and efficacy of the ketogenic diet in children with drug-resistant epilepsy in Vietnam. Epilepsia Open. (2023) 8:1484&#x2013;90. doi: 10.1002/epi4.12825, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/epi4.12825</ArticleId><ArticleId IdType="pmc">PMC10690654</ArticleId><ArticleId IdType="pubmed">37712338</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo A, Corsello A, Spolidoro GCI, Trovato CM, Agostoni C, Orsini A, et al. The influence of ketogenic diet on gut microbiota: potential benefits, risks and indications. Nutrients. (2023) 15:680. doi: 10.3390/nu15173680, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15173680</ArticleId><ArticleId IdType="pmc">PMC10489661</ArticleId><ArticleId IdType="pubmed">37686712</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz B, Lattanzi S, Vonck K, K&#xe4;lvi&#xe4;inen R, Nashef L, Ben-Menachem E. Cenobamate in refractory epilepsy: overview of treatment options and practical considerations. Epilepsia Open. (2023) 8:1241&#x2013;55. doi: 10.1002/epi4.12830, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/epi4.12830</ArticleId><ArticleId IdType="pmc">PMC10690671</ArticleId><ArticleId IdType="pubmed">37743544</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrotti A, Iapadre G, Di Francesco L, Zagaroli L, Farello G. Diet in the treatment of epilepsy: what we know so far. Nutrients. (2020) 12:645. doi: 10.3390/nu12092645, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092645</ArticleId><ArticleId IdType="pmc">PMC7551815</ArticleId><ArticleId IdType="pubmed">32872661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa MS, Shafique MA, Aheed B, Ashraf F, Ali SMS, Iqbal MF, et al. The impact of ketogenic diet on drug-resistant epilepsy in children: a comprehensive review and meta-analysis. Ir J Med Sci (1971 -). (2024) 193:1495&#x2013;503. doi: 10.1007/s11845-024-03622-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-024-03622-8</ArticleId><ArticleId IdType="pubmed">38315271</ArticleId></ArticleIdList></Reference><Reference><Citation>Na J-H, Lee H, Lee Y-M. Clinical efficacy and safety of the ketogenic diet in patients with genetic confirmation of drug-resistant epilepsy. Nutrients. (2025) 17:979. doi: 10.3390/nu17060979, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu17060979</ArticleId><ArticleId IdType="pmc">PMC11945077</ArticleId><ArticleId IdType="pubmed">40290041</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>